Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Low and Intermediate Risk Neuroblastoma Protocol

NCT01728155 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria La Fe as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01728155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Low and Intermediate Risk Neuroblastoma Protocol
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2011
Completion date
Not reported
Enrollment
685 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

low and intermediate paediatric neuroblastoma and neonatal suprarenal masses